Abstract
The recent times have been difficult with the whole world fighting against the COVID-19 pandemic. A herbal home-based spice can help people improve their immunity and fight against this infection. Nigella sativa has been named as a prophetic spice as it has many therapeutic effects. It is found to control diabetes, reduce high cholesterol levels, and serve as an anti- oxidant, anti-cancer, anti-informatory, and immune booster. The compound thymoquinone can be responsible for enhancing the immune system as it acts as an anti-oxidant and has an anti-inflammatory property. Research has shown that to protect yourself from coronavirus, it is important to avoid human contact and strengthen the immune system. This paper is a review of various studies that prove that Nigella sativa can be beneficial in enhancing the immune system and thus fight COVID-19.
Keywords: COVID-19, coronavirus, immunity, Nigella sativa, kalonji, black cumin, onion seed.
Current Traditional Medicine
Title:Nigella sativa, as Preventive Strategy in COVID-19
Volume: 7 Issue: 4
Author(s): Vaishali Mathur and Mahak Sharma*
Affiliation:
- Department of Nutrition and Dietetics, Manav Rachna International Institute of Research and Studies, MAnav Rachna Campus, Sector 43, Delhi Surajkund Road, Faridabad,India
Keywords: COVID-19, coronavirus, immunity, Nigella sativa, kalonji, black cumin, onion seed.
Abstract: The recent times have been difficult with the whole world fighting against the COVID-19 pandemic. A herbal home-based spice can help people improve their immunity and fight against this infection. Nigella sativa has been named as a prophetic spice as it has many therapeutic effects. It is found to control diabetes, reduce high cholesterol levels, and serve as an anti- oxidant, anti-cancer, anti-informatory, and immune booster. The compound thymoquinone can be responsible for enhancing the immune system as it acts as an anti-oxidant and has an anti-inflammatory property. Research has shown that to protect yourself from coronavirus, it is important to avoid human contact and strengthen the immune system. This paper is a review of various studies that prove that Nigella sativa can be beneficial in enhancing the immune system and thus fight COVID-19.
Export Options
About this article
Cite this article as:
Mathur Vaishali and Sharma Mahak *, Nigella sativa, as Preventive Strategy in COVID-19, Current Traditional Medicine 2021; 7 (4) : e190122190566 . https://dx.doi.org/10.2174/2215083807666210121152731
DOI https://dx.doi.org/10.2174/2215083807666210121152731 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanisms of Cardioprotection of Halogenated Agents During Extracorporeal Circulation in Cardiac Surgery
Current Vascular Pharmacology Targeting Transient Receptor Potential Canonical Channels for Diseases of the Nervous System
Current Drug Targets Stroke Subtypes and their Possible Implication in Stroke Prevention Drug Strategies
Current Vascular Pharmacology A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxis
Cardiovascular & Hematological Disorders-Drug Targets Radiological Diagnosis of Renal Thrombosis in Children
Current Pediatric Reviews Energy Remodeling, Mitochondrial Disorder and Heart Failure
Current Pharmaceutical Design Therapeutic Approaches in Vascular Repair Induced by Adult Bone Marrow Cells and Circulating Progenitor Endothelial Cells
Current Pharmaceutical Design The Role of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Drug Development for Ischemic Stroke: From Laboratory to Clinics
Current Vascular Pharmacology Inflammasome as a New Therapeutic Target for Diabetic Complications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Inhibitory Effects of Flavonolignans from Silybum marianum (L.) Gaertn (Milk Thistle) on Function of Aldehyde Oxidase and Xanthine Oxidase in Rats
Letters in Drug Design & Discovery Spinal Cord Injury Changes Cytokine Transport
CNS & Neurological Disorders - Drug Targets Are Chemically Reactive Metabolites Responsible for Adverse Reactions to Drugs?
Current Drug Metabolism Subject Index Volume 6
Mini-Reviews in Medicinal Chemistry Impact of the Renin-Angiotensin-Aldosterone-System on Cardiovascular and Renal Complications in Diabetes Mellitus
Current Vascular Pharmacology Remyelination in Multiple Sclerosis: The Therapeutic Potential of Neural and Mesenchymal Stem/Progenitor Cells
Current Signal Transduction Therapy Influence of a Novel Inhibitor (UM8190) of Prolylcarboxypeptidase (PRCP) on Appetite and Thrombosis
Current Medicinal Chemistry Ryanodine Receptor Patents
Recent Patents on Biotechnology Mesenchymal Stem Cell Therapy in Intracerebral Haemorrhagic Stroke
Current Medicinal Chemistry The Isoprostanes - Unique Products of Arachidonate Peroxidation: Their Role as Mediators of Oxidant Stress
Current Pharmaceutical Design miR-15b Suppression of Bcl-2 Contributes to Cerebral Ischemic Injury and is Reversed by Sevoflurane Preconditioning
CNS & Neurological Disorders - Drug Targets